7 completed. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 7 |
Follow MRI: new trials by email Literature Review of MRI trials Research Report on MRI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase. MRI, MRI control, telephone consultation - Migraine Aura | Phase 4 | Completed | University Hospital, Toulouse | 60 | 2018-12-22 | 2021-02-03 |
| Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases Fludeoxyglucose F-18, Magnetic Resonance Imaging, Positron Emission Tomography - Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm | Phase 4 | Completed | M.D. Anderson Cancer Center | 12 | 2018-08-03 | 2024-05-01 |
| Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI Ferumoxytol-enhanced magnetic resonance imaging, Magentic Resonance Imaging - Osteonecrosis | Phase 4 | Completed | Stanford University | 14 | 2015-05-01 | 2024-11-26 |
| Emotional and Cognitive Control in Late-Onset Depression Escitalopram, Magnetic Resonance Imaging - Depression | Phase 4 | Completed | Weill Medical College of Cornell University | 121 | 2012-07-01 | 2020-10-06 |
| Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment MRI - Breast Neoplasm | Phase 4 | Completed | Karolinska University Hospital | 440 | 2008-02-01 | 2013-05-29 |
| Canadian Pegvisomant Compassionate Study In Acromegalic Patients Pegvisomant treatment, Medical History, demographics, Sign and symptoms: questionnaire - Acromegaly | Phase 4 | Completed | Pfizer | 30 | 2004-11-01 | 2008-04-24 |
| Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric Patients MRI, Gadoversetamide - Pathological Processes | Phase 4 | Completed | Guerbet | 100 | 2002-05-01 | 2017-08-01 |
Acromegaly (1) · Behavioral Symptoms (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Depression (1) · Depressive Disorder (1) · Mental Disorders (1) · Migraine with Aura (1) · Mood Disorders (1) · Neoplasm Metastasis (1) · Osteonecrosis (1) · Pathologic Processes (1)
Guerbet (1) · Karolinska University Hospital (1) · M.D. Anderson Cancer Center (1) · Pfizer (1) · Stanford University (1) · University Hospital, Toulouse (1) · Weill Medical College of Cornell University (1)
United States (4) · Canada (1) · France (1) · Sweden (1)
Alain Viguier, PH (1) · Brita Arver, MD PhD (1) · Dawid Schellingerhout (1) · Eddie Darton, MD (1) · Faith Gunning, Ph.D. (1) · Heike Daldrup-Link, MD, PhD (1)
PMID 20003832, PMID 30224340, PMID 31077981, PMID 31901436, PMID 34611701, PMID 35895056
2017 (1), R01MH097735 (1)